ATXN3 and juvenile Huntington disease: In a Drosophila model of Huntington's disease, co-expression of wild-type ataxin-3 and polyQ-expanded htt resulted in complete restoration of the neurodegeneration that is typically observed with expression of pathogenic htt alone [162].